Human microdialysis.

Area of Science:

• Pharmacokinetics and Drug Metabolism
• Translational Medicine
• Biotechnology

Background:

• Microdialysis is a technique used for decades in animal studies and for approximately 10 years in human pharmacokinetic research.
• It relies on the passive diffusion of compounds across a semipermeable membrane into a perfusate, sampling the interstitial fluid.

Purpose of the Study:

• To highlight the utility and versatility of microdialysis in human pharmacokinetic studies.
• To emphasize its role in measuring tissue drug concentrations, informing drug development, and supporting regulatory submissions.

Main Methods:

• Utilizes a microdialysis probe inserted into tissues to collect interstitial fluid samples.
• Passive diffusion across the probe membrane allows for the collection of intact molecules, excluding proteins and minimizing fluid loss.
• High temporal resolution sampling is achieved, surpassing traditional biopsy or skin blister techniques.

Main Results:

• Microdialysis enables measurement of endogenous compounds and drug penetration in various human tissues.
• Data generated are valuable for pharmacokinetic-pharmacodynamic (PK-PD) modeling, establishing concentration-response relationships, and investigating drug interactions.
• The technique provides crucial human tissue drug concentration data, supporting regulatory requirements for drug efficacy and safety.

Conclusions:

• Microdialysis is a versatile, cost-effective, and adaptable technique for in vivo human tissue sampling.
• It satisfies regulatory demands for drug concentration data at the target site, facilitating compound selection, dose optimization, and therapeutic efficacy assessment.
• Its feasibility across multiple organs and tissues, coupled with commercial availability of equipment, supports its widespread application in clinical research.